Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

310
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
310
Dialysis01:27

Dialysis

1.1K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

545
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
545
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

289
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
289
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

639
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
639
Renal Drug Excretion: Overview01:15

Renal Drug Excretion: Overview

620
As primary excretory organs, the kidneys maintain homeostasis by removing waste substances from the bloodstream. They comprise over a million units called nephrons, which serve as the kidney's functional units.
A nephron consists of two primary structures: the renal corpuscle and the renal tubule. The renal corpuscle contains the glomerulus, a network of capillaries where the first step of renal excretion, glomerular filtration, occurs. Blood pressure forces water, ions, and small molecules...
620

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Relationship between medication class and ambulatory blood pressure profile in the chronic renal insufficiency cohort (CRIC) study.

Journal of human hypertension·2026
Same author

The Prognostic Value of Serum Interleukin-6 Concentrations for 9 Cardiovascular and Mortality Outcomes: The Cross Cohort Collaboration (CCC).

Journal of the American College of Cardiology·2026
Same author

From detection to diagnosis: Early outcomes of a specialized adrenal nodule clinic.

Surgery·2026
Same author

A Field in Transition: Catheter-Based Therapy in the 2026 AHA/ACC Acute Pulmonary Embolism Guideline.

Journal of the American College of Cardiology·2026
Same author

Efficacy of Tonlamarsen in Patients With Uncontrolled Hypertension: The KARDINAL Phase 2 Randomized Clinical Trial.

Journal of the American College of Cardiology·2026
Same author

Cost-Effectiveness of Valve-in-Valve Transcatheter Mitral Valve Replacement Versus Redo Surgical Mitral Valve Replacement for Degenerated Bioprosthetic Mitral Valve.

Structural heart : the journal of the Heart Team·2026
Same journal

Outcome of Patients Presenting With High-Risk Pulmonary Embolism Treated With Mechanical Thrombectomy: A Subgroup Analysis From the STRIKE-PE Study.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same journal

Reduced-Dose vs Full-Dose Direct Oral Anticoagulants for Extended Anticoagulation Therapy in Patients With Venous Thromboembolism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same journal

Safety and Efficacy of a Novel Atrial Flow Regulator in Patients With Severe Pulmonary Arterial Hypertension: The AFR-Prophet Study.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same journal

Therapeutic Manipulation of the Atrial Septum: Tearing Down the Wall.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same journal

Aspiration Thrombectomy in High-Risk Pulmonary Embolism: Mechanical Reperfusion for Thrombosed Arteries Proven Again.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
Same journal

Advanced Needle-Based Strategies for Complex Calcified Peripheral Artery Disease: A Systematic Review.

Journal of the Society for Cardiovascular Angiography & Interventions·2026
查看所有相关文章

相关实验视频

Updated: Jan 9, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K

构建脏消计划的蓝图

Tayyab Shah1, Catherine Vanchiere1, Maria Bonanni2

  • 1Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

Journal of the Society for Cardiovascular Angiography & Interventions
|December 1, 2025
PubMed
概括
此摘要是机器生成的。

脏缩 (RDN) 为高血压提供了一种新的治疗方法. 本指南有助于干预心脏病学家建立 RDN 计划,增强患者护理和在这个不断增长的领域的职业机会.

关键词:
蓝图是一个蓝图.在职业生涯的早期.培训中的同学们脏变质是指脏的变质.

更多相关视频

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

647
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.5K

相关实验视频

Last Updated: Jan 9, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

647
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.5K

科学领域:

  • 心脏病学 心脏病学
  • 干预心脏病学 干预心脏病学
  • 高血压管理 高血压管理

背景情况:

  • 脏缺血 (RDN) 是一种新兴的高血压辅助疗法.
  • 对于患有血压失控的患者来说,尽管采用了传统的治疗方法,但它尤其有益.
  • 最近FDA对RDN系统的批准表明,临床机会越来越大.

研究的目的:

  • 为了提供一个全面的指南,建立脏缺血计划.
  • 概述包括团队发展,培训,工作流程和经济等关键考虑因素.
  • 定位干预心脏病专家,以引领干预高血压护理的进步.

主要方法:

  • 对RDN的当前文献和临床实践指南的审查.
  • 对干预性心脏病团队的程序开发要求的分析.
  • 讨论 RDN 程序的培训途径和工作流集成.

主要成果:

  • 成功实施RDN计划需要多学科的团队合作.
  • 干预心脏病学家必须具备特殊的培训和程序能力.
  • 对工作流程设计和经济规划的结构化方法对于计划的可持续性至关重要.

结论:

  • 干预心脏病专家有很好的地位,可以推进RDN技术.
  • 建立一个RDN计划提供了显著的临床和职业发展机会.
  • 本综述为开发干预性高血压护理专业知识提供了实际的路线图.